David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.58% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 8.87% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
iShares MSCI France ETF
EWQ
$331M
| $2.41M | ﹤0.01% |
67,110
+33,923
| +102% | +$1.27M |
|
|
CGC
2452
CALL
Canopy Growth
CGC
$463M
| $2.41M | ﹤0.01% |
878,700
+142,700
| +19% | +$566K |
|
2453
Cosan
CSAN
$2.79B
| $2.4M | ﹤0.01% |
441,414
+393,784
| +827% | +$2.96M |
|
2454
Cars.com
CARS
$643M
| $2.39M | ﹤0.01% |
138,094
-87,400
| -39% | -$1.53M |
|
2455
AB InBev
BUD
$154B
| $2.39M | ﹤0.01% |
47,789
-25,405
| -35% | -$1.47M |
|
2456
Envista
NVST
$4.48B
| $2.39M | ﹤0.01% |
123,814
-485,067
| -80% | -$9.59M |
|
2457
Howmet Aerospace
HWM
$106B
| $2.39M | ﹤0.01% |
21,828
-462,991
| -95% | -$50.7M |
|
2458
CALL
Fluor
FLR
$7.18B
| $2.38M | ﹤0.01% |
48,300
-74,400
| -61% | -$3.92M |
|
2459
Forestar Group
FOR
$1.47B
| $2.37M | ﹤0.01% |
91,625
+54,891
| +149% | +$1.64M |
|
2460
Chemed
CHE
$7.12B
| $2.37M | ﹤0.01% |
4,480
-8,359
| -65% | -$4.71M |
|
2461
BioCryst Pharmaceuticals
BCRX
$2.47B
| $2.37M | ﹤0.01% |
315,263
+86,173
| +38% | +$654K |
|
2462
PUT
Prudential Financial
PRU
$41.4B
| $2.37M | ﹤0.01% |
20,000
| – | – |
|
2463
Organogenesis Holdings
ORGO
$223M
| $2.36M | ﹤0.01% |
737,443
-672
| -0.1% | -$2.25K |
|
2464
Thryv Holdings
THRY
$86.7M
| $2.36M | ﹤0.01% |
159,332
+74,648
| +88% | +$1.18M |
|
2465
CALL
Petrobras
PBR
$115B
| $2.35M | ﹤0.01% |
182,900
+154,300
| +540% | +$2.15M |
|
2466
Nordson
NDSN
$18.7B
| $2.35M | ﹤0.01% |
11,213
+7,323
| +188% | +$1.81M |
|
2467
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.3B
| $2.34M | ﹤0.01% |
119,900
-2,700
| -2% | -$54.4K |
|
2468
Houlihan Lokey
HLI
$9.2B
| $2.34M | ﹤0.01% |
13,477
+4,483
| +50% | +$789K |
|
2469
Par Pacific Holdings
PARR
$3.75B
| $2.34M | ﹤0.01% |
142,605
-10,351
| -7% | -$175K |
|
2470
MiMedx Group
MDXG
$676M
| $2.34M | ﹤0.01% |
242,942
+113,191
| +87% | +$882K |
|
2471
BrightSpring Health Services
BTSG
$12.1B
| $2.34M | ﹤0.01% |
+137,202
| New | +$2.37M |
|
2472
Public Service Enterprise Group
PEG
$36.5B
| $2.33M | ﹤0.01% |
27,593
-50,771
| -65% | -$4.49M |
|
|
CALY
2473
CALL
Callaway Golf Company
CALY
$2.78B
| $2.33M | ﹤0.01% |
296,600
+9,700
| +3% | +$88.1K |
|
|
CALY
2474
PUT
Callaway Golf Company
CALY
$2.78B
| $2.33M | ﹤0.01% |
296,300
+13,500
| +5% | +$123K |
|
|
CIO
2475
DELISTED
City Office REIT
CIO
| $2.33M | ﹤0.01% |
421,626
+73,722
| +21% | +$405K |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $7.08B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.